Low HPV vax rates missed opportunity to address health inequities

+News

Low HPV vax rates missed opportunity to address health inequities

Amelia Jenkinson, Cathy Stephenson and Swee Tan
Needle and vial
HPV vaccination rates are below target, making the push to close gaps and reduce cancer rates critical [Image: anilakkus on iStock]

With over $150 million spent on HPV-related cancers in three years, improving HPV vaccination rates would cut costs and save lives, write Amelia Jenkinson, Cathy Stephenson and Swee Tan

“Other countries, including Australia, are achieving herd immunity through a high HPV vaccination rate” A health economy study commissioned by t
References
  1. Win Myint TT, McIvor N, Douglas R, et al. Incidence, trends and survival of oropharyngeal squamous cell cancer in Aotearoa New Zealand, 2006–2020. Cancer Epidemiol 2023;85:102393